Skip to main content

Table 10 Adverse events during the study

From: Efficacy and safety of aerosol inhalation of recombinant human interferon α1b (IFNα1b) injection for noninfluenza viral pneumonia, a multicenter, randomized, double-blind, placebo-controlled trial

 RashSore Throat, Dry ThroatLow WBCElevated transaminaseCessation of menstruation (Pregnancy)Total
Control group (n =87)n002013
SeverityModerateSevere 
Relation to the investigational drugUnrelatedUnrelated 
IFNα1b group (n =77)n211105
SeverityMildMildMildModerate 
Relation to the investigational drugPossiblePossibleUnrelatedUnrelated